Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Cancer Immunology, Immunotherapy : CII|May 12, 2021
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinomaTao Fan, Yu Liu, Hengchang Liu, et al.
Annals of Medicine|November 21, 2025
Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort studyWei Guo, Bolun Zhou, Qilin Huai, et al.
Translational Lung Cancer Research|February 17, 2025
The utility and feasibility of three-dimensional reconstruction in surgical planning for multiple pulmonary nodules: a prospective self-controlled studyZhifei Li, Runze Li, Lei Liu, et al.
Nature Communications|November 20, 2021
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLCBin Qiu, Wei Guo, Fan Zhang, et al.
Thoracic Cancer|May 25, 2022
TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinomaYue Peng, Bin Qiu, Fengwei Tan, et al.
Journal of the National Cancer Center|July 22, 2024
Lung cancer risk in non-smoking females with a familial history of cancer: a multi-center prospective cohort study in ChinaFei Wang, Fengwei Tan, Zheng Wu, et al.
DNA and Cell Biology|February 26, 2020
Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and BioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2020
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
The Annals of Thoracic Surgery|February 6, 2026
Surgical and Survival Benefits of Neoadjuvant Targeted Therapy versus Chemoimmunotherapy in Lung Adenocarcinoma: A Dual-center ResearchJiaxi Xu, Kun Wang, Guochao Zhang, et al.
Annals of Palliative Medicine|December 23, 2020
Therapeutic options for resectable second lung tumor after previous pneumonectomy: a SEER database analysisXiangyang Yu, Shugeng Gao, Qi Xue, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Cancer Immunology, Immunotherapy : CII|May 12, 2021
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinomaTao Fan, Yu Liu, Hengchang Liu, et al.
Annals of Medicine|November 21, 2025
Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort studyWei Guo, Bolun Zhou, Qilin Huai, et al.
Translational Lung Cancer Research|February 17, 2025
The utility and feasibility of three-dimensional reconstruction in surgical planning for multiple pulmonary nodules: a prospective self-controlled studyZhifei Li, Runze Li, Lei Liu, et al.
Nature Communications|November 20, 2021
Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLCBin Qiu, Wei Guo, Fan Zhang, et al.
Thoracic Cancer|May 25, 2022
TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinomaYue Peng, Bin Qiu, Fengwei Tan, et al.
Journal of the National Cancer Center|July 22, 2024
Lung cancer risk in non-smoking females with a familial history of cancer: a multi-center prospective cohort study in ChinaFei Wang, Fengwei Tan, Zheng Wu, et al.
DNA and Cell Biology|February 26, 2020
Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and BioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
Journal of Cancer Research and Clinical Oncology|February 28, 2020
Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformaticsWei Guo, Sijin Sun, Lei Guo, et al.
The Annals of Thoracic Surgery|February 6, 2026
Surgical and Survival Benefits of Neoadjuvant Targeted Therapy versus Chemoimmunotherapy in Lung Adenocarcinoma: A Dual-center ResearchJiaxi Xu, Kun Wang, Guochao Zhang, et al.
Annals of Palliative Medicine|December 23, 2020
Therapeutic options for resectable second lung tumor after previous pneumonectomy: a SEER database analysisXiangyang Yu, Shugeng Gao, Qi Xue, et al.
Pageof 16